In another study, riluzole was combined with temozolomide, a chemotherapeutic agent, and tested on GBM cell lines as well as in an orthotopic mouse allograft model of O6-methylguanine DNA methyltransferase (MGMT)-positive GBM. Here, MGMT is linked to glioblastoma.